InvestorsHub Logo
Followers 33
Posts 2856
Boards Moderated 1
Alias Born 10/24/2015

Re: None

Wednesday, 06/24/2020 5:40:10 PM

Wednesday, June 24, 2020 5:40:10 PM

Post# of 274
From AACR II: Allogeneic CAR-T cell products containing 10 gene edits using CRISPR/Cas9 can retain full functionality in vivo and in vitro https://crisprtx.gcs-web.com/static-files/a4025a52-eb19-4cd7-9059-a5e3a09de119

Allogeneic anti-PTK7 CAR-T cells for the treatment of solid tumors https://crisprtx.gcs-web.com/static-files/3efbfeb9-1b40-4368-a4cc-615833bd6b17

Functional and single-cell assessment of CRISPR-modified CAR-T cells from NSCLC patients and healthy donors https://crisprtx.gcs-web.com/static-files/8f11c096-aca7-433b-9e7b-465bc51826d0

Targeting T cell lymphomas with CRISPR/Cas9-generated anti-CD70 allogeneic CAR-T cells https://crisprtx.gcs-web.com/static-files/bbd654ae-0e27-4a29-8ffb-eb2342d853b2
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CRSP News